|
CHML expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.53770354624794E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.56719970334507E-10 |
| Normal-vs-Stage2 |
7.29000000365687E-08 |
| Normal-vs-Stage3 |
2.58160004484864E-09 |
| Normal-vs-Stage4 |
1.40339999954442E-07 |
| Stage1-vs-Stage2 |
5.953600E-01 |
| Stage1-vs-Stage3 |
6.940600E-01 |
| Stage1-vs-Stage4 |
7.391600E-01 |
| Stage2-vs-Stage3 |
8.253800E-01 |
| Stage2-vs-Stage4 |
8.627400E-01 |
| Stage3-vs-Stage4 |
9.755400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.23729948298524E-11 |
| Normal-vs-AfricanAmerican |
3.246000E-04 |
| Normal-vs-Asian |
4.323800000261E-07 |
| Caucasian-vs-AfricanAmerican |
4.555800E-01 |
| Caucasian-vs-Asian |
6.900800E-01 |
| AfricanAmerican-vs-Asian |
6.032600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.72519817612738E-11 |
| Normal-vs-Female |
4.48550085963006E-11 |
| Male-vs-Female |
4.957600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.81179999891867E-08 |
| Normal-vs-Age(41-60Yrs) |
9.42579347906758E-14 |
| Normal-vs-Age(61-80Yrs) |
7.05389999744455E-08 |
| Normal-vs-Age(81-100Yrs) |
1.968960E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.514400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.652400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.877950E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.472420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.519700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.718170E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.268600E-01 |
| Classical-VS-Follicular |
7.716900E-03 |
| Classical-VS-Other |
5.976800E-01 |
| Classical-VS-Normal |
1.52769996653035E-09 |
| Tall-VS-Follicular |
4.890100E-02 |
| Tall-VS-Other |
4.702000E-01 |
| Tall-VS-Normal |
2.003900E-04 |
| Follicular-VS-Other |
7.231200E-01 |
| Follicular-VS-Normal |
1.9388046723634E-11 |
| Other-VS-Normal |
7.358600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.9960036108132E-14 |
| Normal-vs-N1 |
1.2013999795002E-09 |
| N0-vs-N1 |
6.081000E-01 |
|
|
